880 related articles for article (PubMed ID: 16697742)
1. Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.
Ho RH; Tirona RG; Leake BF; Glaeser H; Lee W; Lemke CJ; Wang Y; Kim RB
Gastroenterology; 2006 May; 130(6):1793-806. PubMed ID: 16697742
[TBL] [Abstract][Full Text] [Related]
2. Novel cationic and neutral glycocholic acid and polyamine conjugates able to inhibit transporters involved in hepatic and intestinal bile acid uptake.
Vicens M; Medarde M; Macias RI; Larena MG; Villafaina A; Serrano MA; Marin JJ
Bioorg Med Chem; 2007 Mar; 15(6):2359-67. PubMed ID: 17276074
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of the contribution of sodium-dependent taurocholate co-transporting polypeptide (NTCP) to the hepatic uptake of rosuvastatin, pitavastatin and fluvastatin.
Bi YA; Qiu X; Rotter CJ; Kimoto E; Piotrowski M; Varma MV; Ei-Kattan AF; Lai Y
Biopharm Drug Dispos; 2013 Nov; 34(8):452-61. PubMed ID: 23996477
[TBL] [Abstract][Full Text] [Related]
4. Regulation of rat organic anion transporters in bile salt-induced cholestatic hepatitis: effect of ursodeoxycholate.
Rost D; Herrmann T; Sauer P; Schmidts HL; Stieger B; Meier PJ; Stremmel W; Stiehl A
Hepatology; 2003 Jul; 38(1):187-95. PubMed ID: 12830001
[TBL] [Abstract][Full Text] [Related]
5. Molecular and functional characterization of bile acid transport in human hepatoblastoma HepG2 cells.
Kullak-Ublick GA; Beuers U; Paumgartner G
Hepatology; 1996 May; 23(5):1053-60. PubMed ID: 8621133
[TBL] [Abstract][Full Text] [Related]
6. Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity.
Kim RB; Leake B; Cvetkovic M; Roden MM; Nadeau J; Walubo A; Wilkinson GR
J Pharmacol Exp Ther; 1999 Dec; 291(3):1204-9. PubMed ID: 10565843
[TBL] [Abstract][Full Text] [Related]
7. Determination of OATP-, NTCP- and OCT-mediated substrate uptake activities in individual and pooled batches of cryopreserved human hepatocytes.
De Bruyn T; Ye ZW; Peeters A; Sahi J; Baes M; Augustijns PF; Annaert PP
Eur J Pharm Sci; 2011 Jul; 43(4):297-307. PubMed ID: 21605667
[TBL] [Abstract][Full Text] [Related]
8. Expression and transport function of drug uptake transporters in differentiated HepaRG cells.
Kotani N; Maeda K; Debori Y; Camus S; Li R; Chesne C; Sugiyama Y
Mol Pharm; 2012 Dec; 9(12):3434-41. PubMed ID: 22897388
[TBL] [Abstract][Full Text] [Related]
9. Differential effect of genetic variants of Na(+)-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors.
Choi MK; Shin HJ; Choi YL; Deng JW; Shin JG; Song IS
Xenobiotica; 2011 Jan; 41(1):24-34. PubMed ID: 20946088
[TBL] [Abstract][Full Text] [Related]
10. Age-dependent activity of the uptake transporters Ntcp and Oatp1b2 in male rat hepatocytes: from birth till adulthood.
Fattah S; Augustijns P; Annaert P
Drug Metab Dispos; 2015 Jan; 43(1):1-8. PubMed ID: 25305012
[TBL] [Abstract][Full Text] [Related]
11. Contribution of sodium taurocholate co-transporting polypeptide to the uptake of its possible substrates into rat hepatocytes.
Kouzuki H; Suzuki H; Ito K; Ohashi R; Sugiyama Y
J Pharmacol Exp Ther; 1998 Aug; 286(2):1043-50. PubMed ID: 9694967
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta.
Le Vee M; Gripon P; Stieger B; Fardel O
Drug Metab Dispos; 2008 Feb; 36(2):217-22. PubMed ID: 17991769
[TBL] [Abstract][Full Text] [Related]
13. Interaction of fluvastatin with the liver-specific Na+ -dependent taurocholate cotransporting polypeptide (NTCP).
Greupink R; Dillen L; Monshouwer M; Huisman MT; Russel FG
Eur J Pharm Sci; 2011 Nov; 44(4):487-96. PubMed ID: 21945488
[TBL] [Abstract][Full Text] [Related]
14. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.
Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB
Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247
[TBL] [Abstract][Full Text] [Related]
15. Maternal cholestasis does not affect the ontogenic pattern of expression of the Na+/taurocholate cotransporting polypeptide (ntcp) in the fetal and neonatal rat liver.
Arrese M; Trauner M; Ananthanarayanan M; Boyer JL; Suchy FJ
Hepatology; 1998 Sep; 28(3):789-95. PubMed ID: 9731574
[TBL] [Abstract][Full Text] [Related]
16. Hepatic basolateral sodium-dependent-bile acid transporter expression in two unusual cases of hypercholanemia and in extrahepatic biliary atresia.
Shneider BL; Fox VL; Schwarz KB; Watson CL; Ananthanarayanan M; Thevananther S; Christie DM; Hardikar W; Setchell KD; Mieli-Vergani G; Suchy FJ; Mowat AP
Hepatology; 1997 May; 25(5):1176-83. PubMed ID: 9141436
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the endothelin receptor antagonists ambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich-cultured human hepatocytes.
Lepist EI; Gillies H; Smith W; Hao J; Hubert C; St Claire RL; Brouwer KR; Ray AS
PLoS One; 2014; 9(1):e87548. PubMed ID: 24498134
[TBL] [Abstract][Full Text] [Related]
18. Sinusoidal (basolateral) bile salt uptake systems of hepatocytes.
Hagenbuch B; Meier PJ
Semin Liver Dis; 1996 May; 16(2):129-36. PubMed ID: 8781018
[TBL] [Abstract][Full Text] [Related]
19. Molecular regulation of sinusoidal liver bile acid transporters during cholestasis.
Gartung C; Matern S
Yale J Biol Med; 1997; 70(4):355-63. PubMed ID: 9626756
[TBL] [Abstract][Full Text] [Related]
20. Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine.
Simonson SG; Raza A; Martin PD; Mitchell PD; Jarcho JA; Brown CD; Windass AS; Schneck DW
Clin Pharmacol Ther; 2004 Aug; 76(2):167-77. PubMed ID: 15289793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
